The survival time of patients with diabetic peripheral neuropathy is related to the severity of the disease, the patient’s physical condition, and the control of the primary disease.
In general, high medication compliance, smooth glycemic control and active treatment in the early stage of the disease basically do not affect the quality of life and life expectancy of patients. If other serious diseases are also combined, clinical evaluation is required on a case-by-case basis and cannot be generalized.